SABBY Management, LLC, 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 60,200 shares at $0.28 ($17K) on 2019-01-29, disclosed to the SEC on 2019-01-31.
Open-market purchase of $17k RSLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.28 | 12,200 | $3K | 20.3% |
| 2 | $0.28 | 48,000 | $13K | 79.7% |
| Total | $0.28 avg | 60,200 | $17K | 100% |
| Filing → |
| VLCN | BUY | 2024-08-28 | $5K | — | Filing → |
| VLCN | BUY | 2024-08-26 | $11K | — | Filing → |
| VLCN | SELL | 2024-08-26 | $134K | — | Filing → |